课题基金 / 基金详情

Investigation of the Mechanism of Fulminant and Severe Hepatitis Correlated with Hepatitis B Virus Mutations

Investigation of the Mechanism of Fulminant and Severe Hepatitis Correlated with Hepatitis B Virus Mutations
乙型肝炎病毒突变相关暴发性和重型肝炎的机制研究
批准号:
03454223
负责人:
OMATA Masao
金额:
$3.46万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993

项目摘要

项目成果

OMATA Masao的其他基金

相似基金

相关文献

中文摘要
翻译
B型肝炎病毒感染可导致广泛的肝损伤,包括自限性急性肝炎、暴发性肝炎和慢性肝炎进展为肝硬化或急性加重为肝功能衰竭,以及非对称性慢性携带状态。B型肝炎核心抗原可能是细胞毒性T淋巴细胞(CTL)的免疫靶点。为了研究为什么会发生严重的免疫攻击,对整个前核心区和核心区进行了测序。所有无症状健康携带者和自限性急性肝炎患者的推导氨基酸残基均无明显变化。而慢性重型肝病和重型肝炎患者的小片段氨基酸呈聚集性变化。这些结果表明,这些突变区域可能在B肝炎病毒疾病的发病机制中起重要作用,这些突变与严重的肝损害有关。最近的研究表明,与I类人淋巴细胞抗原(HLA)结合的内源性加工病毒肽可被CTL识别,加工病毒肽的大小可小至9个氨基酸。为了研究CTL识别HBV多肽与HLA I类分子结合的机制,我们已经建立了一种利用亲和柱层析从肝细胞中分离HLA I类分子的方法。我们已经开始分析从纯化的HLA I类分子洗脱的此类肽。
英文摘要
Hepatitis B virus infection leads to a wide spectrum of liver injury, including self-limited acute hepatitis, fulminant hepatitis and chronic hepatitis with progression to cirrhosis or acute exacerbation to liver failure, as well as asymtomatic chronic carrier state. The hepatitis B core antigen could be an immunological target of cytotoxic T lymphocytes (CTL). To investigate the reason why the severe immunological attack occurs, the entire precore and core region was sequenced. No significant change in deduced amino acid residuewas noted in all the asymptomatic healthy carrires and all the self-limited acute hepatitis patients. In contrast, clustering changes in small segments of amino acids were found in all the patients with severe chronic liver disease and the fatal hepatitis cases. These data suggest that these regions with mutation may play an important role in the pathogenesis of hepatitis B viral disease, and such mutations are related to severe liver damage.Recent studies revealed that the endogenously processed viral peptides bound to the class I human lymphocyte antigen (HLA) are recognized by CTLs and the size of the processed viral peptide could be as small as 9 amino acids. To study the mechanism how CTLs recognize HBV peptides bound to HLA Class I molecules, we have already established a method to separate HLA Class I molecules from hepatocytes using an affinity colum chromatography. We have started to analyze such peptides eluted from purified HLA class I molecules.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
Takano S,Omata M et al.: "Prospective assessment of incidence of ful-minant hepatitis in post-transfusion hepatitis" Dig Dis Sci. 39. 28-32 (1994)
Takano S、Omata M 等人:“输血后肝炎中暴发性肝炎发生率的前瞻性评估”Dig Dis Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ehata,T.: "Variations in codon 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection." J Clin Invest. 89. 332-338 (1992)
Ehata,T.:“核心核苷酸序列中密码子 84-101 的变异与慢性乙型肝炎病毒感染的肝细胞损伤相关。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokosuka O,Omata M et al.: "Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein:detection of anti-hepatitis C core antibody by western blot." Dig Dis Sci. 38. 626-630 (1993)
Yokosuka O、Omata M 等人:“丙型肝炎病毒核心蛋白作为与麦芽糖结合蛋白的融合蛋白的表达:通过蛋白质印迹检测抗丙型肝炎核心抗体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ehata T,Omata M et al: "Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis." J Clin Invest. 91. 1206-1213 (1993)
Ehata T、Omata M 等人:“乙型肝炎病毒核心核苷酸序列的突变与暴发性和重症肝炎相关。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    Inhibition of innate immune system by hepatitis C virus
    • 批准号:
      17209026
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.37万
    • 财政年份:
      2005
    • 负责人:
      OMATA Masao
    • 依托单位:
    Mechanism of hepatocyte injury via survival and death signaling induced by hepatitis viruses
    • 批准号:
      13307019
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.53万
    • 财政年份:
      2001
    • 负责人:
      OMATA Masao
    • 依托单位:
    The molecular mechanism of te pathogenesis induced by Helicbacter phylori (TN2) and the clinical application
    • 批准号:
      11557040
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.19万
    • 财政年份:
      1999
    • 负责人:
      OMATA Masao
    • 依托单位:
    Molecular diagrostic assays for hepatic, pancreatic and gastrointestinal cancers
    • 批准号:
      07557044
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $9.02万
    • 财政年份:
      1995
    • 负责人:
      OMATA Masao
    • 依托单位:
    海外基金